239 related articles for article (PubMed ID: 25791675)
1. Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Cohen A; Suzanne P; Lancelot JC; Verhaeghe P; Lesnard A; Basmaciyan L; Hutter S; Laget M; Dumètre A; Paloque L; Deharo E; Crozet MD; Rathelot P; Dallemagne P; Lorthiois A; Sibley CH; Vanelle P; Valentin A; Mazier D; Rault S; Azas N
Eur J Med Chem; 2015 May; 95():16-28. PubMed ID: 25791675
[TBL] [Abstract][Full Text] [Related]
2. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
3. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
4. A natural product based DOS library of hybrid systems.
Prabhu G; Agarwal S; Sharma V; Madurkar SM; Munshi P; Singh S; Sen S
Eur J Med Chem; 2015 May; 95():41-8. PubMed ID: 25794788
[TBL] [Abstract][Full Text] [Related]
5. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
[TBL] [Abstract][Full Text] [Related]
6. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
7. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.
Lee S; Lim D; Lee E; Lee N; Lee HG; Cechetto J; Liuzzi M; Freitas-Junior LH; Song JS; Bae MA; Oh S; Ayong L; Park SB
J Med Chem; 2014 Sep; 57(17):7425-34. PubMed ID: 25137549
[TBL] [Abstract][Full Text] [Related]
8. Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.
Rodrigues CA; Frade RF; Albuquerque IS; Perry MJ; Gut J; Machado M; Rosenthal PJ; Prudêncio M; Afonso CA; Moreira R
ChemMedChem; 2015 May; 10(5):883-90. PubMed ID: 25784585
[TBL] [Abstract][Full Text] [Related]
9. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections.
Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ
Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.
Quiliano M; Pabón A; Moles E; Bonilla-Ramirez L; Fabing I; Fong KY; Nieto-Aco DA; Wright DW; Pizarro JC; Vettorazzi A; López de Cerain A; Deharo E; Fernández-Busquets X; Garavito G; Aldana I; Galiano S
Eur J Med Chem; 2018 May; 152():489-514. PubMed ID: 29754074
[TBL] [Abstract][Full Text] [Related]
11. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents.
Primas N; Suzanne P; Verhaeghe P; Hutter S; Kieffer C; Laget M; Cohen A; Broggi J; Lancelot JC; Lesnard A; Dallemagne P; Rathelot P; Rault S; Vanelle P; Azas N
Eur J Med Chem; 2014 Aug; 83():26-35. PubMed ID: 24946216
[TBL] [Abstract][Full Text] [Related]
13. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
[TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages.
Weidner T; Lucantoni L; Nasereddin A; Preu L; Jones PG; Dzikowski R; Avery VM; Kunick C
Malar J; 2017 May; 16(1):192. PubMed ID: 28502250
[TBL] [Abstract][Full Text] [Related]
15. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
16. Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages.
Roberts BF; Iyamu ID; Lee S; Lee E; Ayong L; Kyle DE; Yuan Y; Manetsch R; Chakrabarti D
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):85-92. PubMed ID: 27054067
[TBL] [Abstract][Full Text] [Related]
17. Re-Engineering of Yohimbine's Biological Activity through Ring Distortion: Identification and Structure-Activity Relationships of a New Class of Antiplasmodial Agents.
Paciaroni NG; Perry DL; Norwood VM; Murillo-Solano C; Collins J; Tenneti S; Chakrabarti D; Huigens RW
ACS Infect Dis; 2020 Feb; 6(2):159-167. PubMed ID: 31913597
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of existing therapeutics to combat drug-resistant malaria.
Yadav K; Shivahare R; Shaham SH; Joshi P; Sharma A; Tripathi R
Biomed Pharmacother; 2021 Apr; 136():111275. PubMed ID: 33485067
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antimalarial activity and cytotoxicity of extracts and fractions from the leaves, root-bark and stem-bark of Triclisia gilletii.
Kikueta CM; Kambu OK; Mbenza AP; Mavinga ST; Mbamu BM; Cos P; Maes L; Apers S; Pieters L; Cimanga RK
J Ethnopharmacol; 2013 Sep; 149(2):438-42. PubMed ID: 23876596
[TBL] [Abstract][Full Text] [Related]
20. Blood schizontocidal and gametocytocidal activity of 3-hydroxy-N'-arylidenepropanehydrazonamides: a new class of antiplasmodial compounds.
Leven M; Held J; Duffy S; Tschan S; Sax S; Kamber J; Frank W; Kuna K; Geffken D; Siethoff C; Barth S; Avery VM; Wittlin S; Mordmüller B; Kurz T
J Med Chem; 2014 Oct; 57(19):7971-6. PubMed ID: 25195945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
